1 completed, 1 terminated. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Triolein: new trials by email Literature Review of Triolein trials Research Report on Triolein
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Study of Beta Interferon and Thalidomide in Patients With Adrenoleukodystrophy glyceryl trierucate, glyceryl trioleate, interferon beta - Adrenoleukodystrophy | Not applicable | Completed | FDA Office of Orphan Products Development | 60 | 1998-08-01 | 2015-03-25 |
| Effect of Glycerol Trierucate on Clinical Course of Adrenoleukodystrophy glyceryl trierucate/glyceryl trioleate - Adrenoleukodystrophy | Phase 2 | Terminated | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 126 | 1998-04-01 | 2020-10-23 |
Adrenoleukodystrophy (2) · Metabolism, Inborn Errors (2) · Rare Diseases (2) · Sphingolipidoses (2)
FDA Office of Orphan Products Development (1) · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1)
United States (1)
Gerald V Raymond, M.D. (1) · Hugo Wolfgang Moser (1)